Bladder Cancer - Results from #180

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture. October 12, 2021

A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer. October 12, 2021

Recombinant BCGs for tuberculosis and bladder cancer. October 11, 2021

Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians. October 11, 2021

Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non-muscle-invasive bladder cancer: Pro. October 11, 2021

Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion. October 11, 2021

Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency. October 9, 2021

Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection. October 9, 2021

Perioperative outcomes of intracorporeal robot-assisted radical cystectomy versus open radical cystectomy: A systematic review and meta-analysis of comparative studies. October 8, 2021

γδ T cells support antigen-specific αβ T cell-mediated antitumor responses during BCG treatment for bladder cancer. October 7, 2021

M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer. October 7, 2021

The Journal of Urology Publishes Results of the Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer October 6, 2021

Association between surgical volume and survival among patients with variant histologies of bladder cancer. October 6, 2021

Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial. October 6, 2021

Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status. October 5, 2021

DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo. October 5, 2021

First-Ever Global Bladder Cancer Patient Experience Survey Launches Online, Led by the World Bladder Cancer Patient Coalition October 4, 2021

Association of prior local therapy and outcomes with PD(L)1 inhibitor in advanced urothelial cancer. October 4, 2021

Urine Biomarkers for the Diagnosis of Bladder Cancer: a Network Meta-Analysis. October 4, 2021

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. October 1, 2021

Page 10 of 417

email news signup